Chemotherapy for peripheral T-cell lymphoma


Published: June 10, 2009
Abstract Views: 130
PDF: 121
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Over the past two decades, increased understanding of the immune system and genetic abnormalities associated with non-Hodgkin’s lymphoma (NHL) have led to the identification of several previously unrecognized types of lymphoma including a variety of T-cell lymphomas.1-5 This recognition of clinically relevant subtypes led to a proposal for changing the lymphoma classification which incorporated some aspects of the Kiel classification6 and the Working Formulation.7 Eventually the World Health Organization (WHO) classification was proposed8 and independently evaluated.9

Supporting Agencies


Vose, J. (2009). Chemotherapy for peripheral T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 2(13). https://doi.org/10.4081/hmr.v2i13.501

Downloads

Citations